Table 1 Baseline Characteristics for 12,845 Patients With and Without Diabetes
From: Diabetes and the occurrence of infection in primary care: a matched cohort study
Variable | Diabetes (n = 1779) | Non-Diabetes (n = 11,066) | P value |
|---|---|---|---|
Age | < 0.001 | ||
Mean (SD) | 57.5 (15.6) | 43.1 (16.5) | |
Median (IQR) | 59.0 (20) | 41.0 (26) | |
Gender n, (%) | |||
Male | 889 (50.0) | 4435 (40.1) | < 0.001 |
Female | 890 (50.0) | 6631 (59.9) | < 0.001 |
Doctor Visits (Mean, SD) | 3.7 (3.9) | 3.3 (3.8) | 0.015 |
Referral To a Specialist, n (%) | |||
0 | 1568 (88.1) | 9927 (89.7) | 0.05 |
1 | 133 (7.5) | 755 (6.8) | 0.338 |
≥2 | 78 (4.4) | 384 (3.5) | 0.064 |
Infection before 1-year entry, n (%) | |||
0 | 1385 (77.8) | 6261 (56.6) | < 0.001 |
1 | 203 (11.4) | 1894 (17.1) | < 0.001 |
≥2 | 191 (10.7) | 2911 (26.3) | < 0.001 |
Lab Tests (Mean, SD) | 14.5 (46.3) | 10.6 (33.2) | < 0.001 |
Vaccines, n (%) | 251 (14.1) | 1202 (10.9) | < 0.001 |
Acid-suppressing Medications, n (%) | 306 (17.2) | 983 (8.9) | < 0.001 |
Respiratory Medications, n (%) | 173 (9.72) | 1140 (10.3) | 0.482 |
Lipid-lowering Medications, n (%) | 716 (40.2) | 653 (5.9) | < 0.001 |
Microvascular Disease, n (%) | 29 (1.6) | 23 (0.2) | < 0.001 |
Macrovascular Disease, n (%) | 76 (4.3) | 111 (1) | < 0.001 |
Heart failure, n (%) | 19 (1.1) | 16 (0.1) | < 0.001 |
Fatty Liver, n (%) | 10 (0.6) | 12 (0.1) | < 0.001 |
Obesity, n (%) | 61 (3.4) | 129 (1.2) | < 0.001 |
Respiratory Disease, n (%) | 236 (13.3) | 2273 (20.5) | < 0.001 |
Follow up time, years (Mean, SD) | 4.2 (1.7) | 4.2 (1.7) | 0.788 |